Mengxin Li
Key Laboratory Of Pathobiology
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Histone acetyltransferase Kat2a regulates glioma stem cell differentiation via Hsp90aa1-dependent oxidative phosphorylation.
Journal: Biochemical pharmacology
Published: May 16, 2026
Integrative PANoptosis-focused omics analysis uncovers GSDMC as a candidate biomarker in breast cancer.
Journal: Frontiers in cell and developmental biology
Published: March 28, 2026
The relationship between sarcopenia and breast cancer: mechanistic pathways and clinical relevance.
Journal: Frontiers in cell and developmental biology
Published: October 24, 2025
Case Report: A rare case of thyroid metastasis from breast cancer.
Journal: Frontiers in oncology
Published: August 27, 2025
The function of CD164 in breast cancer and its possibility as a molecular biomarker: bioinformatics analysis and experimental validation.
Journal: Frontiers in immunology
Published: March 28, 2025
Taxifolin promotes glioma stem cell differentiation via CYP1B1-mediated EMT suppression.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 09, 2025
Transglutaminase 2 promotes breast cancer cell autophagy by targeting p53/ mTOR axis.
Journal: Biochemical pharmacology
Published: January 08, 2025
RSL3 sensitizes glioma cells to ionizing radiation by suppressing TGM2-dependent DNA damage repair and epithelial-mesenchymal transition.
Journal: Redox biology
Published: October 18, 2024
Transglutaminase 2 in breast cancer metastasis and drug resistance.
Journal: Frontiers in cell and developmental biology
Published: August 23, 2024
cAMP response element-binding protein: A credible cancer drug target.
Journal: The Journal of pharmacology and experimental therapeutics
Published: August 17, 2024
Roles of Copper Transport Systems Members in Breast Cancer.
Journal: Cancer medicine
Published: June 12, 2024
GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: August 18, 2023
Last Updated: 09/26/2026